American Healthcare REIT (AHR) is considered a better investment choice with higher dividend yield and potential upside than Rithm Capital.
In a head-to-head comparison, American Healthcare REIT (AHR) appears to be the better investment choice based on several factors, such as a higher dividend yield (7.2% vs. Rithm Capital's 8.9%), higher potential upside (14.46% increase vs. 6.86%), and institutional investor ownership (16.68% vs. 44.9% for Rithm Capital). AHR received a "Moderate Buy" consensus rating from eight research firms, with an average 12-month price target of $15.88.
April 30, 2024
4 Articles